Ratio of two successive optical densities from the Roche HIV-1 Monitor Test as a measure of accuracy of estimates of human immunodeficiency virus RNA concentration

被引:2
作者
Jennings, C
Brambilla, DJ
Bremer, JW
机构
[1] Rush Med Coll, Dept Microbiol Immunol, Chicago, IL 60612 USA
[2] New England Res Inst Inc, Watertown, MA 02472 USA
关键词
D O I
10.1128/JCM.40.3.1067-1068.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In the Roche Amplicor HIV-1 Monitor Test, the ratio of the optical density used to estimate the RNA concentration and the optical density of the preceding or the following dilution can be used to identify specimens with inaccurate results which should be retested. We present an algorithm for the identification of such results.
引用
收藏
页码:1067 / 1068
页数:2
相关论文
共 12 条
[1]   Variability in repeated consecutive measurements of plasma human immunodeficiency virus RNA in persons receiving stable nucleoside reverse transcriptase inhibitor therapy or no treatment [J].
Bartlett, JA ;
DeMasi, R ;
Dawson, D ;
Hill, A .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (06) :1803-1805
[2]   The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements [J].
Brambilla, D ;
Reichelderfer, PS ;
Bremer, JW ;
Shapiro, DE ;
Hershow, RC ;
Katzenstein, DA ;
Hammer, SM ;
Jackson, B ;
Collier, AC ;
Sperling, RS ;
Fowler, MG ;
Coombs, RW .
AIDS, 1999, 13 (16) :2269-2279
[3]   Multisite comparison of reproducibility and recovery from the standard and ultrasensitive Roche AMPLICOR HIV-1 MONITOR assays [J].
Brambilla, DJ ;
Granger, S ;
Jennings, C ;
Bremer, JW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :1121-1123
[4]   Effect of errors in the sequence of optical densities from the Roche AMPLICOR HIV-1 MONITOR assay on the validity of assay results [J].
Brambilla, DJ ;
Granger, S ;
Jennings, C ;
Bremer, JW .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (03) :1118-1120
[5]   Monitoring plasma HIV-1 RNA levels in addition to CD4(+) lymphocyte count improves assessment of antiretroviral therapeutic response [J].
Hughes, MD ;
Johnson, VA ;
Hirsch, MS ;
Bremer, JW ;
Elbeik, T ;
Erice, A ;
Kuritzkes, DR ;
Scott, WA ;
Spector, SA ;
Basgoz, N ;
Fischl, MA ;
DAquila, RT .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :929-938
[6]   The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter [J].
Katzenstein, DA ;
Hammer, SM ;
Hughes, MD ;
Gundacker, H ;
Jackson, JB ;
Fiscus, S ;
Rasheed, S ;
Elbeik, T ;
Reichman, R ;
Japour, A ;
Merigan, TC ;
Hirsch, MS .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (15) :1091-1098
[7]   Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm3 (ACTG 175) [J].
Lathey, JL ;
Hughes, MD ;
Fiscus, SA ;
Pi, T ;
Jackson, JB ;
Rasheed, S ;
Elbeik, T ;
Reichman, R ;
Japour, A ;
D'Aquila, RT ;
Scott, W ;
Griffith, BP ;
Hammer, SM ;
Katzenstein, DA .
JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) :617-624
[8]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170
[9]   QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION [J].
MELLORS, JW ;
KINGSLEY, LA ;
RINALDO, CR ;
TODD, JA ;
HOO, BS ;
KOKKA, RP ;
GUPTA, P .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :573-579
[10]   Use of HIV viral load in clinical practice: Back to the future [J].
Saag, MS .
ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :983-985